Shares of DaVita Inc. /zigman2/quotes/204229673/composite DVA +0.99% inched 0.91% higher to $91.27 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.22% rising 0.66% to 4,006.18 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.0047% rising 0.61% to 31,774.52. This was the stock's fifth consecutive day of gains. DaVita Inc. closed $39.20 below its 52-week high ($130.47), which the company achieved on September 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Fresenius Medical Care AG & Co. KGaA ADR /zigman2/quotes/210057637/composite FMS +1.64% fell 4.34% to $16.31, Laboratory Corp. of America Holdings /zigman2/quotes/203174601/composite LH +0.61% rose 2.73% to $238.27, and Universal Health Services Inc. Cl B /zigman2/quotes/208539347/composite UHS -0.19% rose 0.36% to $101.24. Trading volume (509,078) remained 264,119 below its 50-day average volume of 773,197.